Rob Stein
Stories
-
Science
Pandemic Is Overwhelming U.S. Public Health Capacity In Many States. What Now?
With the coronavirus spreading out of control in many parts of the U.S., some experts say the strategy of testing and tracing can't contain the pandemic until lockdowns bring case numbers down.
-
Science
Gene Therapy Shows Promise For Hemophilia, But Could Be Most Expensive U.S. Drug Ever
The first gene therapy for hemophilia could be approved by the FDA within six months, according to the drugmaker, raising hopes among families. But the drug's price could be $3 million per patient.
-
Health
U.S. Wants To Ramp Up COVID-19 Testing To 100 Million A Month By September
Why is the US suffering such a shortage of testing? The Trump administration is promising to perform 100 million tests by September. Is that realistic?
-
National
U.S. Hits 2 Million Coronavirus Cases As Many States See A Surge Of Patients
New cases are rising in at least 20 states, even as restrictions on daily life continue to ease. The U.S. total represents more than 25% of the confirmed cases worldwide.
-
National
Race, Ethnicity Data To Be Required With Coronavirus Tests In U.S.
The federal government says that as of Aug. 1, all laboratories must include detailed demographic data when reporting test results in order to help fight the pandemic nationally.
-
Health
CDC Director Says New Analysis Exonerates Agency On Testing Delay
CDC chief Robert Redfield says that earlier testing for the coronavirus would have been like "looking for a needle in a haystack." But other health experts dispute his assertion.
-
Health
Scientists Warn CDC Testing Data Could Create Misleading Picture Of Pandemic
The CDC combines results of a test that spots people who are actively infected with another one that looks for antibodies. Scientists say it could create a false picture of the pandemic.
-
Health
Getting An Antibody Test For The Coronavirus? Here's What It Won't Tell You
As more and more people get tested for antibodies to the coronavirus, infectious disease specialists worry that those tested — and their employers — may not understand the limits of the results.
-
Health
FDA Worries COVID-19 Test Misses Too Many People Who Are Infected
The Food And Drug Administration is raising concerns about the accuracy of the Abbott ID Now Coronavirus test, which returns results within 15 minutes. The FDA worries about false negative results.
-
Health
A Next-Generation Coronavirus Test Raises Hopes And Concerns
An antigen test could be quick, and much simpler and cheaper than the PCR tests now used to spot people infected with the novel coronavirus. But some scientists worry about an antigen test's accuracy.